Top 8 Joint Implant Manufacturers in 2026

Zimmer Biomet is one of the most established names in joint reconstruction, with broad offerings across primary and revision knee replacement, total and partial knee procedures, primary hip replacement and revision hip systems. Its scale, installed base and long-standing hospital relationships make it a frequent benchmark when distributors compare knee replacement manufacturers.

The company’s relevance is not limited to implant breadth. Its joint portfolio is connected to planning, data and robotic-assisted workflows, while established knee and hip families give procurement teams multiple fixation and procedural options. For distributors, that breadth can support large institutional accounts, but it may also involve more complex contracting, training and capital-equipment considerations.

Distributor perspective: Best suited to markets that prioritize brand recognition, extensive procedural coverage and a mature technology ecosystem. Confirm which implant families, instruments and enabling technologies are supported locally.

Stryker combines a substantial hip and knee implant portfolio with a prominent technology-enabled joint replacement ecosystem. Its knee offering is widely associated with the Triathlon family, while its hip business covers femoral and acetabular solutions for different approaches and fixation strategies.

A major differentiator is the connection between implants, planning and robotic-assisted workflows. This can be valuable for hospital programs seeking a standardized procedural platform, but buyers should evaluate the full economic model rather than comparing implant prices alone. Capital equipment, service, consumables, training and utilization can all affect the total program cost.

Distributor perspective: Strong fit for technology-led joint programs and institutions that value a connected implant and robotic workflow. Regional access and distribution arrangements should be reviewed early.

DePuy Synthes maintains a broad joint reconstruction portfolio within Johnson & Johnson MedTech. Its knee systems, hip stems, acetabular components and enabling technologies give hospitals access to an integrated arthroplasty offering supported by a large global organization.

The company is relevant to both knee implant manufacturer and hip replacement manufacturer comparisons because of its depth across primary procedures, revision needs and digital or robotic-assisted workflows. Distributors should still assess product availability at the regional level, since commercial structure and supported systems can vary by country.

Recent industry discussions have highlighted ongoing strategic reviews within the orthopedic sector. Distributors evaluating long-term partnerships should monitor material corporate developments while focusing their due diligence on product continuity, regulatory support, local service and supply capability.

Distributor perspective: Appropriate for established hospital networks seeking a recognizable full-line joint reconstruction partner. Validate the exact contracting channel, instrument support and continuity plan for the target market.

Smith+Nephew has an established reconstruction business covering knee and hip implants, supported by technologies for planning and robotic-assisted procedures. Its knee portfolio includes primary and revision options, while its hip range covers stems, cups and bearing-related choices for different procedural requirements.

The company is often differentiated by the way it connects implant systems with surgical workflow technologies. For distributors, this creates a value proposition that extends beyond the implant itself, but it also makes local technical service, user training and system utilization important parts of supplier evaluation.

Distributor perspective: Relevant for hospital customers looking for an established reconstruction portfolio with technology-enabled workflows. Compare regional implant availability, service capacity and instrument-set requirements.

Enovis has expanded its position in reconstructive orthopedics through portfolio development and acquisitions, including the addition of LimaCorporate. The resulting business covers knee, hip and extremity reconstruction and gives the group a broader international manufacturing and commercial footprint.

For joint distributors, Enovis represents an alternative to the largest legacy arthroplasty groups, with a combination of established implant families and design-led reconstruction technologies. Because portfolio integration can evolve after major acquisitions, buyers should request a current product map rather than relying on older brand catalogs.

Distributor perspective: Worth considering for buyers seeking a growing reconstruction platform with broader category coverage. Confirm current brand ownership, regional registrations, instrument availability and post-acquisition support channels.

Corin is a focused joint reconstruction company with hip and knee systems supported by planning and positioning technologies. Its specialist profile gives it a different market position from broad orthopedic conglomerates whose joint business sits alongside many unrelated categories.

The company’s emphasis on personalized planning and functional positioning can be relevant to hospitals seeking a differentiated arthroplasty workflow. For distributors, the opportunity depends on whether this specialist proposition matches local surgeon demand and whether the required planning, training and technical support can be delivered consistently.

Distributor perspective: A strong specialist candidate for portfolios built around hip and knee reconstruction rather than full-line orthopedics. Evaluate technology access and local case-support requirements alongside implant economics.

MicroPort Orthopedics offers knee and hip reconstruction systems with a recognizable focus on medial-pivot knee design and tissue-sparing hip procedure concepts. Its portfolio connects Chinese corporate roots with an established international orthopedic business, making it relevant to distributors comparing global brands and Asia-linked manufacturers.

The company can be attractive where buyers want a differentiated implant philosophy rather than a direct copy of the largest brands’ portfolios. As with any multinational supplier, the practical evaluation should focus on the exact systems registered in the target country, replenishment capability and access to complete instruments.

Distributor perspective: Suitable for markets where surgeon interest in medial-pivot knees or tissue-sparing hip workflows creates a clear commercial proposition. Verify local training resources and instrument logistics.

Medacta has built a distinctive profile through joint implants, minimally invasive procedure concepts and patient-specific planning. Its hip business is closely associated with the AMIS approach, while its knee offering includes implant systems and personalized planning options such as MyKnee.

This combination positions Medacta as more than an implant catalog. The company’s model places substantial weight on technique, education and a coordinated procedural workflow. That can create differentiation for distributors, but it also requires a realistic plan for surgeon engagement, training and case support.

Distributor perspective: Well suited to partners capable of supporting education-led market development. Assess whether the target market can sustain the procedural and training model before focusing on implant price.